FDA Inspection
Marksans Pharma LimitedMarksans Pharma Limited – FDA Inspection, Apr 7, 2017
Record Details
This FDA Inspection record concerns Marksans Pharma Limited, with an inspection on April 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0a46e527-596f-4cd1-9fa8-39b7af5c0d5f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1014460
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Marksans Pharma Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 4, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 6, 2019 | Not classified | Office of Inspections and Investigations | |
| September 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Marksans Pharma Limited
- FDA Inspection 1236614 - 2024-04-17
- FDA Inspection 1211415 - 2023-08-04
- FDA Inspection 1086017 - 2019-03-06
- FDA Inspection 944722 - 2015-09-03
- FDA Inspection 795367 - 2012-08-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.